Find clinical trials for Pancreatic Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near New York, NY, USA:
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
New York, New York, United States and 12 other locations
This research study is studying a combination of interventions as a possible treatment for pancreatic tumor.The interventions invol...
Phase 2
New York, New York, United States and 9 other locations
study of PBP1510 administered to patients with advanced/metastatic pancreatic cancer. The study will be conducted in two parts, Par...
Phase 1, Phase 2
New Hyde Park, New York, United States and 2 other locations
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer...
Phase 2
New York, New York, United States and 16 other locations
The purpose of this study is to evaluate the safety or treating pancreatic cancer with surgery to remove cancerour tissue, followed...
Phase 1
New York, New York, United States and 6 other locations
This study will evaluate the safety and tolerability of escalating doses of L-DOS47 in combination with doxorubicin, as well as preliminary anti-tumor...
Phase 1, Phase 2
Morristown, New Jersey, United States and 2 other locations
open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...
Phase 1, Phase 2
New York, New York, United States and 15 other locations
and PD-L1 t-haNK in subjects with locally advanced or metastatic pancreatic cancer. Each treatment setting (ie, first line maintena...
Phase 2
East Brunswick, New Jersey, United States and 3 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
New York, New York, United States of America and 135 other locations
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
New York, New York, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal